Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Up 28,800.0% in April

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 28,900 shares, a growth of 28,800.0% from the March 31st total of 100 shares. Based on an average daily trading volume, of 22,100 shares, the days-to-cover ratio is currently 1.3 days.

Nexien BioPharma Price Performance

Nexien BioPharma stock opened at $0.02 on Friday. The company has a market capitalization of $1.37 million, a price-to-earnings ratio of -2.03 and a beta of 1.60. Nexien BioPharma has a one year low of $0.01 and a one year high of $0.10. The company’s fifty day moving average price is $0.02 and its two-hundred day moving average price is $0.02.

About Nexien BioPharma

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.